Fallopian Tube: HGSOC Origin, Prevention, Treatment
Received Date: Apr 01, 2025 / Published Date: Apr 29, 2025
Abstract
The fallopian tube is increasingly recognized as the origin site for high-grade serous ovarian carcinoma (HGSOC), with serous tubal intraepithelial carcinoma (STIC) identified as a precursor. Research highlights the management of fallopian tube carcinoma, its genomic similarities to HGSOC (including BRCA1/2 mutations), and the potential for PARP inhibitors. Preventative strategies like opportunistic salpingectomy are advocated. Imaging, prognostic factors, novel therapies (PARP inhibitors, immunotherapy), early detection biomarkers, and mechanisms of chemoresistance are actively investigated. Neoadjuvant chemotherapy shows promise for advanced cases. This collective knowledge is crucial for advancing prevention, diagnosis, and personalized treatment of this disease.
Citation: Gomez ME (2025) Fallopian Tube: HGSOC Origin, Prevention, Treatment. Current Trends Gynecol Oncol 10: 265.
Copyright: 漏 2025 Maria E. Gomez This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted聽use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 623
- [From(publication date): 0-0 - Apr 09, 2026]
- Breakdown by view type
- HTML page views: 467
- PDF downloads: 156
